申请人:Konradi W. Andrei
公开号:US20060013799A1
公开(公告)日:2006-01-19
Disclosed are conjugates which bind VLA-4. Certain of these conjugates also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such conjugates are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The conjugates can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
公开的是结合VLA-4的偶联物。其中一些偶联物还能抑制白细胞粘附,特别是VLA-4介导的白细胞粘附。这类偶联物可用于治疗哺乳动物患者,如人类的炎症性疾病,例如哮喘、阿尔茨海默病、动脉粥样硬化、艾滋病痴呆、糖尿病、炎症性肠病、类风湿性关节炎、组织移植、肿瘤转移和心肌缺血。这些偶联物还可用于治疗炎症性脑病,如多发性硬化症。